Leukemia Research
Volume 30, Issue 9 , Pages 1069-1071 , September 2006

Interferon regulatory factor-1 myelodysplasia and leukemia

Received 8 March 2006

References 

  1. Fujita T, Kimura Y, Miyamoto M, Barsoumian EL, Taniguchi T. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatorytranscription factor IRF-1. Nature. 1989;337:270–272
  2. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T. Absence of the type 1 IFN system in EC cells: transcriptionalactivator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell. 1990;63:303–312
  3. Miyamoto M, Fugita T, Kimura Y, Maruyama M, Harada H, Sudo Y, et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell. 1988;54:903–913
  4. Abdollahi A, Lord K, Hoffman-Liebermann B, Liebermann D. Interferon regulatory factor-1 is a myeloid differentiation primary response gene induced by IL6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 1991;2:401–407
  5. Passioura T, Dolnikov A, Shen S, Symonds G. N-ras-induced growth suppression of myeloid cells is mediated by IRF-1. Cancer Res. 2005;65(3):797–804
  6. Squier MK, Sehnert AJ, Cohen JJ. Apoptosis in leukocytes. J Leukoc Biol. 1995;57:2–10
  7. Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, et al. Target ed disruption of IRF-1 or IRF-2 results in abnormal type 1 IFN gene induction and aberrant lymphocyte development. Cell. 1993;75:83–97
  8. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, et al. An IRF-1-dependent pathway of DNA damage-induced apoptosis inmitogen-activated T lymphocytes. Nature. 1995;376:596–599
  9. Tendler DS, Bao C, Wang T, Huang EL, Ratovitski EA, Pardoll DA, et al. Intersection of interferon and hypoxiasignal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res. 2001;61:3682–3688
  10. Tendler DS, Bao C, Wang T, Huang EL, Ratovitski EA, Pardoll DA, et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis. Cancer Res. 2001;61:3682–3688
  11. Liu J, Guan X, Ma X. Interferon regulatory factor-1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CC15 expression in macrophages. J Biol Chem. 2005;280(26):24347–24355
  12. Liebermann DA, Hoffman B. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia. 2002;16:527–541
  13. Liebermann DA, Hoffman B. Myeloid differentiation (MyD) primary response genes in hematopoiesis. Blood Cells Mol Dis. 2003;31(2):213–228
  14. Willman CL, Sever CE, Palavicini MG, Harada H, Tanaka N, Slovak ML, et al. Deletion of IRF-1, mapping to chromosome 5q31.1, inhuman leukemia and preleukemic myelodysplasia. Science. 1993;259:968–971
  15. Green WB, Slovak ML, Chen IM, Pallavicini M, Hecht JL, Willman CL. Lack of IRF-1 expression in acute promyelocytic leukemia and in a subset of acute myeloid leukemias with del(5)(q31). Leukemia. 1999;13(12):1960–1971
  16. Harada H, Kondo T, Ogawa S, Tamura T, Kitagawa M, Tanaka N, et al. Accel-eratedexonskipping of IRF-1 mRNA in human myelodysplasia/leukemia; apossible mechanism of tumor sup-pressorinactivation. Oncogene. 1994;9:3313–3320
  17. Mayeda A, Helfman DM, Krainer AR. Modulation of exon skipping and inclusion by heterogeneous nuclearribonucleoprotein A1 and pre-mRNAsplicing factor SF2/ASF. Mol Cell Biol. 1993;13:2993–3001
  18. Tzoanopoulos D, Speletas M, Arvanitidis K, Veiopoulou C, Kyriaki S, Thyphronitis G, et al. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia. Br J Haematol. 2002;119(1):46–53
  19. Maratheftis CI, Bolaraki PE, Giannouli S, Kapsogeorgou EK, Moutsopoulos HM, Voulgarelis M. Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells. Leuk Res. 2006;30:1177–1185
  20. Harada H, Takahashi E, Itoh S, Harada K, Hori TA, Taniguchi T. Structure and regulation of the human interferon regulatory factor-1 (IRF-1) and IRF-2 genes: implications for a gene network in theinterferon system. Mol Cell Biol. 1994;14:1500–1509
  21. Kirchhoff S, Oumard A, Nourbakhsh M, Levi BZ, Hauser H. Interplay between repressing and activating domains defines the transcriptional activity of IRF-1. Eur J Biochem. 2000;267:6753–6761
  22. Chelbi-alix MK, Bobe P, Benoit G, Canova A, Pine R. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1. Oncogene. 2003;22(57):9121–9130
  23. Clarke N, Jimenez-Lara AM, Voltz E, Gronemeyer H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J. 2004;23(15):3051–3060

PII: S0145-2126(06)00102-0

doi: 10.1016/j.leukres.2006.03.001

Leukemia Research
Volume 30, Issue 9 , Pages 1069-1071 , September 2006

Article Tools